Protagen's Series A Round

Protagen raised a round of funding on August 12, 2009.

Protagen uses its proprietary SeroTag biomarker platform to identify disease specific autoantibodies and is on target to become the leading provider of autoimmune diagnostic products, specifically tar…

Articles about Protagen's Series A Round: